首页>
外国专利>
COMBINED USE OF CLINICAL RISK FACTORS AND MOLECULAR MARKERS OF THROMBOSIS FOR CLINICAL DECISION SUPPORT
COMBINED USE OF CLINICAL RISK FACTORS AND MOLECULAR MARKERS OF THROMBOSIS FOR CLINICAL DECISION SUPPORT
展开▼
机译:临床风险因素和血栓形成分子标志物联合用于临床决策支持
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine.;SUBSTANCE: group of inventions relates to the field of clinical decision support and can be used to calculate an estimation value of thrombosis risk of a patient based on patient-specific input features. In the method, an apparatus comprises: a data interface for receiving said input features; a processor for calculating said estimation value by applying a decision support algorithm as a function of numerical values derived from said received input features; and a user interface for outputting said estimation value; wherein said input features include a combination of at least one clinical risk factor for thrombosis, at least one single nucleotide polymorphism and at least one protein level of said patient, which are indicators of thrombosis. Further, the method includes: selecting said input features to provide a combination of at least one clinical risk factor for thrombosis, at least one single nucleotide polymorphism and at least one protein level of said patient, which are indicators of thrombosis; and calculating the aforementioned assessment value by applying a decision support algorithm as a function of the numerical values obtained from the said received input features. Further, a computer-readable storage medium that has a computer software installed on it containing a program code, which, being executed on the computer device, makes this computer device to carry out the steps of the method on the apparatus.;EFFECT: group of inventions provides an increase in the effectiveness of clinical decision support.;15 cl, 2 tbl, 8 dwg
展开▼